Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Digital video systems vendor SeaChange International Inc. of Maynard, Mass. and on-and off-site secure DICOM storage vendor InSiteOne have formed a strategic partnership.
IBM is providing Teges Corp. of Coral Gables, Fla. with its WebSphere software that enables doctors making their rounds to enter or access patient information using speech, a keyboard or handwriting via handheld, slate tablet PCs.
OTech's Spring 2005 webcast will occur on Tuesday, Feb. 22nd at 10AM CST to cover topics such as: "How to avoid common mistakes when implementing a PACS" in addition to "Getting ready for HIPAA security."
Siemens Medical Solutions and NextGen Healthcare Information Systems, a provider of ambulatory Electronic Medical Records (EMR) and practice management software, announced a worldwide strategic alliance intended to meet the distinctive healthcare IT needs
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
